NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials
Anticoagulation Forum/LinkedIn
Aug 5, 2025, 18:17

Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials

Anticoagulation Forum shared an inviting post on LinkedIn:

”Just 2 days away! Don’t miss our upcoming webinar: Secondary VTE Prevention: To Reduce or Not to Reduce?

Thursday, August 7 | 12:00 PM ET

We are excited to welcome another expert to our panel: Naomi Yates, PharmD, BCACP, who will join as a moderator to help guide this dynamic conversation on one of the most debated questions in anticoagulation: what’s the right dose, and when should it be reduced?

This live webinar will explore key findings from the RENOVE and API-CAT trials, framed by a historical lens and brought to life by a panel of expert clinicians.

What you’ll learn:

  • DOAC dosing strategies for extended secondary VTE prevention
  • Evidence-based guidance for individualizing care
  • Practical takeaways for real-world treatment

Speakers:
Arthur Allen, PharmD, CACP
Jean Connors, MD
Stephan Moll, MD
Naomi Yates, PharmD, BCACP

There’s still time to register and bring your clinical questions to the panel.”

Register here.

Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials

Stay updated on all conferences, webinars and panel discussions on coagulation disorders with Hemostasis Today.

Anticoagulation Anticoagulation Forum APICAT Arthur Allen DOAC Headlines Health Hematology Hemostasis Today Jean Connors Medicine Naomi Yates RENOVE Secondary VTE Prevention Stephan Moll VTE
NewsFeed